PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Health Economics10.1002/hec.342620162543-56Household Financial Distress and Initial Endowments: Evidence from the 2008 Financial CrisisArna Olafssonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhec.3426, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhec.3426, https://onlinelibrary.wiley.com/doi/full/10.1002/hec.3426
Evidence-Based Child Health: A Cochrane Review Journal10.1002/ebch.1986201494749-750Pros and cons …Michael B.H. Smithhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Febch.1986, https://onlinelibrary.wiley.com/doi/full/10.1002/ebch.1986
Solving Modern Crime in Financial Markets10.1016/b978-0-12-804494-0.00033-42016465-470Pros and Cons of Stronger Financial Regulation?Marius-Christian Frunzahttps://api.elsevier.com/content/article/PII:B9780128044940000334?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128044940000334?httpAccept=text/plain
PharmacoEconomics & Outcomes News10.2165/00151234-200905770-000232009577110-10Generics vs brand name drug pricing: pros and cons debatedhttp://link.springer.com/content/pdf/10.2165/00151234-200905770-00023.pdf, http://link.springer.com/article/10.2165/00151234-200905770-00023/fulltext.html, http://link.springer.com/content/pdf/10.2165/00151234-200905770-00023.pdf
PharmacoEconomics & Outcomes News10.1007/bf03272259199714119-9Pros & cons of insulin for NIDDMhttp://link.springer.com/content/pdf/10.1007/BF03272259.pdf, http://link.springer.com/article/10.1007/BF03272259/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03272259
PharmacoEconomics & Outcomes News10.1007/bf0326973819964412-2Pros and cons of critical pathways for improving healthcarehttp://link.springer.com/content/pdf/10.1007/BF03269738.pdf, http://link.springer.com/article/10.1007/BF03269738/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03269738
PharmacoEconomics & Outcomes News10.1007/bf0327021519967712-2Pros and cons of managed care for psychiatric disordershttp://link.springer.com/content/pdf/10.1007/BF03270215.pdf, http://link.springer.com/article/10.1007/BF03270215/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03270215
PharmacoEconomics & Outcomes News10.1007/bf0327013419967016-7Pros & cons of disease- and patient-specific outcome measureshttp://link.springer.com/content/pdf/10.1007/BF03270134.pdf, http://link.springer.com/article/10.1007/BF03270134/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03270134
PharmacoEconomics & Outcomes News10.1007/bf0329291419967512-2Healthy-years-equivalents: the pros and conshttp://link.springer.com/content/pdf/10.1007/BF03292914.pdf, http://link.springer.com/article/10.1007/BF03292914/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03292914
The Muslim World10.1111/j.1478-1913.2007.00158.x200797133-78Pros and Cons: Americanism against Islamism in the ‘War on Terror’Sayres S. Rudyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1478-1913.2007.00158.x